ScreenerHero

GLMDGalmed Pharmaceuticals Ltd.

NAS · US · Healthcare · Biotechnology · galmedpharma.com
4.305USDMkt Cap: 4.48M $P/E: —

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap4.48M $
Enterprise Value-11.77M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.31M $
Revenue/Share—
Last Price4.305 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.43
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B2.16
EPS (TTM)-16.48
EPS (Forward)-1.03
52W Range
4.12044% of range4.540
52W High4.540 USD
52W Low4.120 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-65.32%
ROA-55.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.32M $
CapEx (TTM)—
FCF Margin—
FCF Yield-111.28%
Net Debt-15.45M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio7.71
Quick Ratio7.65
Book Value/Sh2.113 USD
Cash/Share18.73 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateAug 19, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.04M
Float798.29K
Insiders3.04%
Institutions1.89%
Short Interest
Short Ratio0.2d
Short % Float1.82%
Short % Out.1.78%
Shares Short18.37K
Short (prev mo.)9.29K
Technical
SMA 504.511 (-4.6%)
SMA 2005.680 (-24.2%)
Beta0.68
S&P 52W Chg21.00%
Avg Vol (30d)21.41K
Avg Vol (10d)41.81K
Technical Indicators
RSI (14)56.9
MACD0.8985
MACD Signal0.7356
MACD Hist.+0.1629
BB Upper6.740 USD
BB Middle2.725 USD
BB Lower-1.2893 USD
BB Width294.63%
ATR (14)1.046 USD
Vol Ratio (20d)0.10x